MB21D2, a key enzyme involved in the cGAS/STING signaling pathway, is also frequently mutated in NSCLC and HNSCC to promote tumor progression (Campbell et al., 2016; Gracilla et al., 2020). The gene discussed is STING1; the disease is head and neck squamous cell carcinoma.